Health care stocks were higher late Friday afternoon, with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR Fund (XLV) rising 0.4%.
The iShares Biotechnology ETF (IBB) increased 0.2%.
In corporate news, Sanofi (SNY) is close to finalizing a deal this weekend to sell control of its consumer health unit Opella to Clayton Dubilier & Rice, Bloomberg reported. Sanofi shares added 0.2%.
Bright Minds Biosciences (DRUG) shares soared 159% after the company said Friday that it launched a private placement of shares at $21.70 apiece.
CVS Health (CVS) shares tumbled past 5%. The company said Friday it named David Joyner as its new chief executive, while issuing a preliminary Q3 earnings outlook that came in below analysts' estimates.
Orgenesis (ORGS) shares plunged 35% after the company said in a regulatory filing it was notified that the Nasdaq hearings panel has decided to delist its shares and suspend trading, effective Monday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。